| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 9, 2002
Accepted on April 14, 2003
1 Karolinska Institute, Department of Biosciences at Novum, SE-14157 Huddinge, Sweden; Centre de recherche, Hôpital Sainte-Justine, Département de Pédiatrie, Université de Montréal, Quebec, Canada.
* To whom correspondence should be addressed. E-mail: kada{at}cbt.ki.se.
Several isoforms of estrogen receptor
(ER
, NR3A2) have been reported, including variants with different N terminal ends. In rodents, two in frame ATGs are used to produce proteins of 530 and 549 amino acids, respectively. In humans, the upstream ATG is out of frame in all clones reported, until recently, when human clones with an extra A-T bp placing the upstream ATG in frame were reported. The authors suggested that this could represent a novel polymorphism in the ER
gene. Since human ER
548 (hER
548) and hER
530 display different functional characteristics in vitro, it is of interest to determine if this variant constitutes a polymorphism in human populations. We therefore determined the frequency of this novel isoform in several populations including African (n = 96), Caucasian (n = 100) and Asian (n = 128) subjects using Denaturing High-Performance Liquid Chromatography (DHPLC). We did not detect any alleles that correspond to hER
548 in these samples or in additional samples of heterogeneous origin. It is concluded that hER
548 is not a common variant in Africans, Caucasians or Asians.
548
polymorphism
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |